Investigation of the Interaction of Some Alkaloids Derived from Marine Algae’s with Human Acetylcholinesterase: In Silico Study Anti- Acetylcholinesterase Activity of Some Alkaloids
Archives of Advances in Biosciences,
Vol. 13 No. 1 (2022),
1 Dey 2022
,
Page 1-9
https://doi.org/10.22037/aab.v13i2.38273
Abstract
Introduction: Nowadays, acetylcholinesterase inhibitors are commonly used to improve the symptoms of Alzheimer's disease and central nervous system disorders. Marine algae’s contain compounds like alkaloids that have many biological activities. We aimed to investigate the inhibitory effects of some alkaloids with human acetylcholinesterase using molecular docking.
Materials and Methods: In this study, the interaction of 19 alkaloid compounds with human acetylcholinesterase (hAChE) was investigated using molecular docking. The initial structure of the compounds was optimized using mm2 method by Chem3D software; the compounds were evaluated as inhibitors on the gap of the active site of the enzyme by AutodackVina software, and the output results were analyzed by Discovery Studio software.
Results: The results showed that most of these compounds act as inhibitors with good binding energy (-7.7 to -9.8 kcal/mol). The best performance is related to the three compounds including Caulerpin, Martefragin A and N-Acetyl tyramine. Caulerpin was involved in hydrogen bonding with an affinity of -9.6 with the amino acids Histidine: 405, Arginine: 296, and Asparagine: 233. Martefragin A was involved in hydrogen bonding with an affinity of -9.6 with the amino acids Serine: 293, Phenylalanine: 295, and Arginine: 296, respectively. N-Acetyl tyramine was involved in hydrogen bonding with an affinity of -9.8 with the amino acids Asparagine: 186, Lysine: 53, and Glycine: 14.
Conclusion: The results of this study suggest that most of these alkaloid compounds can inhibit this enzyme by binding to the cleavage site of the active site of hAChE, and thus are suitable options for further studies to design new anticholinesterase drugs.
- Alkaloids, Acetylcholinesterase, Alzheimer disease, Molecular docking simulation
How to Cite
References
Kumar A, Singh A. A review on Alzheimer's disease pathophysiology and its management: an update. Pharmacol Rep. 2015; 67(2):195-203. [DOI: 10.1016/j.pharep.2014.09.004] [PMID]
Chen ZR, Huang JB, Yang SL, Hong FF. Role of cholinergic signaling in Alzheimer’s disease. Molecules. 2022; 27(6):1816. [DOI:10.3390/molecules27061816] [PMID]
Kamkwalala A, Newhouse P. Beyond acetylcholinesterase inhibitors: novel cholinergic treatments for Alzheimer’s disease. Curr Alzheimer Res. 2017; 14(4):377-92. [DOI:10.2174/1567205013666160930112625] [PMID]
Maloney B, Lahiri DK. Epigenetics of dementia: understanding the disease as a transformation rather than a state. Lancet Neurol. 2016; 15(7):760-74. [DOI:10.1016/S1474-4422(16)00065-X] [PMID]
Sharma S, Bhatia V. Phytochemicals for drug discovery in Alzheimer’s disease: In silico advances. Curr Pharm Des. 2021; 27(25):2848-60. [DOI:10.2174/138161282 6666200928161721] [PMID]
Cheng S, Song W, Yuan X, Xu Y. Gorge motions of acetylcholinesterase revealed by microsecond molecular dynamics simulations. Sci Rep. 2017; 7(1):1-2. [DOI:10.1038/s41598-017-03088-y] [PMID] [PMCID]
Li J, Gu F, Wu R, Yang J, Zhang KQ. Phylogenomic evolutionary surveys of subtilase superfamily genes in fungi. Sci Rep. 2017; 7(1):1-5. [DOI:10.1038/srep45456] [PMID]
Almeida JS, Cavalcante SF, Dolezal R, Kuca K, Musilek K, Jun D, et al. Molecular modeling studies on the interactions of aflatoxin B1 and its metabolites with the peripheral anionic site of human acetylcholinesterase. J Biomol Struct Dyn. 2019; 37(8):2041-8. [DOI:10.1080/07391102.2018.1475259] [PMID]
Jeltsch A, Jurkowska RZ. Allosteric control of mammalian DNA methyltransferases–a new regulatory paradigm. Nucleic Acids Res. 2016; 44(18):8556-75. [DOI:10.1093/nar/gkw723] [PMID]
Kaur RA, Arora SA. Alkaloids-important therapeutic secondary metabolites of plant origin. J Crit Rev. 2015; 2(3):1-8. http://www.jcreview.com/admin/Uploads/ Files/61c722e77020b8.87584317.pdf
Nepi M, Grasso DA, Mancuso S. Nectar in plant–insect mutualistic relationships: from food reward to partner manipulation. Front. Plant Sci. 2018; 9:1-14. [DOI:10.3389/fpls.2018.01063] [PMID] [PMCID]
Pérez MJ, Falqué E, Domínguez H. Antimicrobial action of compounds from marine seaweed. Mar Drugs. 2016; 14(3):52. [DOI: 10.3390/md14030052] [PMID] [PMCID]
Badri S, Basu VR, Chandra K, Anasuya D. A review on pharmacological activities of alkaloids. Int J Curr Med Pharm Res. 2019; 1(6):230-4. [DOI:10.37022/WJCMPR. 2019.01068]
Güven KC, Percot A, Sezik E. Alkaloids in marine algae. Mar Drugs. 2010; 8(2):269-84. [DOI:10.3390/md8020269] [PMID]
Souza CR, Bezerra WP, Souto JT. Marine alkaloids with anti-inflammatory activity: Current knowledge and future perspectives. Mar Drugs. 2020; 18(3):1-17. [DOI:10.3390/md18030147] [PMID]
Omidi B, SarveAhrabi Y. In Vitro and In Silico Evaluation of Biological Properties of Some 1, 3, 4-Oxadiazole Derivatives Against Streptococcus mutans and Their Interaction With Gbp-C by Molecular Docking. Avicenna J Dent Res. 2021; 13(4):142-7. [DOI:10.34172/ajdr.2021.27]
Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010; 31(2):455-61. [DOI:10.1002/jcc.21334] [PMID]
Ravindranath PA, Forli S, Goodsell DS, Olson AJ, Sanner MF. AutoDockFR: advances in protein-ligand docking with explicitly specified binding site flexibility. PLoS Comput. Biol. 2015; 11(12):1-28. [DOI:10.1371/journal.pcbi.1004586] [PMID][PMCID]
Agrawal P, Singh H, Srivastava HK, Singh S, Kishore G, Raghava GPS. Benchmarking of different molecular docking methods for protein-peptide docking. BMC Bioinformatics. 2019; 19(13):105-24. [DOI:10.1186/s12859-018-2449-y] [PMID] [PMCID]
Liu D, Liu Y, Shen A, Li X, Yu L, et al. Analysis of alkaloids in Gelsemium elegans Benth using an online heart-cutting+ comprehensive RPLC× RPLC system tandem mass spectrometry. Talanta. 2022; 239:123069. [DOI:10.1016/j.talanta.2021.123069] [PMID]
Jain C, Khatana S, Vijayvergia R. Bioactivity of secondary metabolites of various plants: a review. Int J Pharm Sci Res. 2019; 10(2):494-504. [DOI:10.13040/IJPSR.0975-8232.10(2).494-04]
Gonçalves KG, da Silva LL, Soares AR, Romeiro NC. Acetylcholinesterase as a target of halogenated marine natural products from Laurencia dendroidea. Algal Res. 2020; 52:102130. [DOI:10.1016/j.algal.2020.102130]
Cinar E, Taskin E, Tasdemir D, Ozkale E, Grienke U, Firsova D. Anti-Acetylcholinesterase, Antiprotozoal and Cytotoxic Activities of some turkish marine algae. Fresenius Environ. Bull. 2019; 28:3991-4000. https://hero.epa.gov/hero/index.cfm/reference/details/reference_id/7738593
Zhang Y, Kua J, McCammon JA. Role of the catalytic triad and oxyanion hole in acetylcholinesterase catalysis: an ab initio QM/MM study. J Am Chem Soc. 2002; 124(35):10572-7. [DOI:10.1021/ja020243m] [PMID]
Damuka N, Kammari K, Potshangbam AM, Rathore RS, Kondapi AK, Vindal V. Discovery of dual cation-π inhibitors of acetylcholinesterase: design, synthesis and biological evaluation. Pharmacol Rep. 2020; 72(3):705-18. [DOI:10.1007/s43440-020-00086-2] [PMID]
Wiesner J, Kříž Z, Kuča K, Jun D, Koča J. Acetylcholinesterases–the structural similarities and differences. J Enzyme Inhib Med Chem. 2007; 22(4):417-24. [DOI:10.1080/14756360701421294] [PMID]
Atanasova M, Yordanov N, Dimitrov I, Berkov S, Doytchinova I. Molecular docking study on galantamine derivatives as cholinesterase inhibitors. Mol Inform. 2015; 34(6‐7):394-403. [DOI:10.1002/minf.201400145] [PMID]
Moghadam B, Ashouri M, Roohi H, Karimi-Jafari MH. Computational evidence of new putative allosteric sites in the acetylcholinesterase receptor. J Mol Graph Model. 2021; 107:107981. [DOI:10.1016/j.jmgm.2021.107981] [PMID]
Parvez M, Ara J, Sultana V, Qasim R, Ahmad VU. Caulerpin. Acta Cryst. 2000; 56(3):96-7. [DOI: 10.1107/S0108270100001529] [PMID]
Liu DQ, Mao SC, Zhang HY, Yu XQ, Feng MT, et al. Racemosins A and B, two novel bisindole alkaloids from the green alga Caulerpa racemosa. Fitoterapia. 2013; 91:15-20. [DOI:10.1016/j.fitote.2013.08.014] [PMID]
Netz N, Opatz T. Marine indole alkaloids. Mar Drugs. 2015; 13(8):4814-914. [DOI:10.3390/md13084814] [PMID]
Percot A, Yalçın A, Aysel V, Erdugan H, Dural B, et al. β-Phenylethylamine content in marine algae around Turkish coasts. Botanica Marina. 2009; 52(1):87-90. [DOI:10.1515/BOT.2009.031]
Gandy S. The role of cerebral amyloid β accumulation in common forms of Alzheimer disease. J Clin Investig. 2005; 115(5):1121-9. [DOI:10.1172/JCI25100] [PMID] [PMCID]
Liu Y, Yan B, Winkler DA, Fu J, Zhang A. Competitive inhibition mechanism of acetylcholinesterase without catalytic active site interaction: Study on functionalized C60 nanoparticles via in vitro and in silico assays. ACS Appl Mater Interfaces. 2017; 9(22):18626-38. [DOI:10.1021/acsami.7b05459] [PMID]
Iraji A, Khoshneviszadeh M, Firuzi O, Khoshneviszadeh M, Edraki N. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands. Bioorg Chem. 2020; 97:103649. [DOI:10.1016/j.bioorg.2020.103649] [PMID]
- Abstract Viewed: 326 times
- PDF Downloaded: 30 times
- MP3 Downloaded: 20 times